Products for Research Use Only
RegisterLogin

MRE-269 (ACT-333679)

CAT: 0957-S5819-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0957-S5819-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
MRE-269 (ACT-333679) is a prostaglandin I2 (IP) receptor agonist with a binding affinity for the human IP receptor that is 130-fold greater than that for other human prostanoid receptor.
CAS Number
475085-57-5
Target
Prostaglandin Receptor
Activity
GPCR & G Protein
Molecular Formula
C25H29N3O3
Storage Conditions
3 years -20°C powder

Related Products

CatalogName
E1941-01ACT-1016-0707
E1941-25mgACT-1016-0707
S5753-01Setipiprant (ACT-129968)
E1941-100mgACT-1016-0707
E1941-5mgACT-1016-0707
E1941-1gACT-1016-0707
S5753-25mgSetipiprant (ACT-129968)
S4996-01Tavaborole (AN-2690)
S4996-25mgTavaborole (AN-2690)
S4996-1gTavaborole (AN-2690)

Alternative Products

CatalogName
C11380-5mgMRE-269 (ACT-333679)
A18322-100MRE-269 (ACT-333679) 100mg
A18322-5MRE-269 (ACT-333679) 5mg
A18322-50MRE-269 (ACT-333679) 50mg
A18322-25MRE-269 (ACT-333679) 25mg
A18322-10MRE-269 (ACT-333679) 10mg
AR-S01245-01MRE-269-Glucuronide (ACT-333679-Glucuronide)
AR-S01244-01MRE-269-d6 (ACT-333679-d6)
A18322-10mM-DMRE-269 (ACT-333679) 10mM * 1mL in DMSO
AR-S10084-01Selexipag Metabolite N-Oxide (MRE-269 N-Oxide, ACT-333679 N-Oxide)

Popular Products